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1Although improvements in evidence-based therapies during primary percutaneous coronary intervention 
(PPCI) have substantially reduced mortality after an acute 
ST-segment–elevation myocardial infarction (STEMI), the 
onset of heart failure is on the rise.1–3 Microvascular obstruc-
tion (MVO) occurs in ≈50% of reperfused STEMI patients,4 
Background—The presence of intramyocardial hemorrhage (IMH) in ST-segment–elevation myocardial infarction patients 
reperfused by primary percutaneous coronary intervention has been associated with residual myocardial iron at follow-
up, and its impact on adverse left ventricular (LV) remodeling is incompletely understood and is investigated here.
Methods and Results—Forty-eight ST-segment–elevation myocardial infarction patients underwent cardiovascular magnetic 
resonance at 4±2 days post primary percutaneous coronary intervention, of whom 40 had a follow-up scan at 5±2 months. 
Native T1, T2, and T2* maps were acquired. Eight out of 40 (20%) patients developed adverse LV remodeling. A subset 
of 28 patients had matching T2* maps, of which 15/28 patients (54%) had IMH. Eighteen of 28 (64%) patients had 
microvascular obstruction on the acute scan, of whom 15/18 (83%) patients had microvascular obstruction with IMH. 
On the follow-up scan, 13/15 patients (87%) had evidence of residual iron within the infarct zone. Patients with residual 
iron had higher T2 in the infarct zone surrounding the residual iron when compared with those without. In patients with 
adverse LV remodeling, T2 in the infarct zone surrounding the residual iron was also higher than in those without (60 
[54–64] ms versus 53 [51–56] ms; P=0.025). Acute myocardial infarct size, extent of microvascular obstruction, and IMH 
correlated with the change in LV end-diastolic volume (Pearson’s rho of 0.64, 0.59, and 0.66, respectively; P=0.18 and 
0.62, respectively, for correlation coefficient comparison) and performed equally well on receiver operating characteristic 
curve for predicting adverse LV remodeling (area under the curve: 0.99, 0.94, and 0.95, respectively; P=0.19 for receiver 
operating characteristic curve comparison).
Conclusions—The majority of ST-segment–elevation myocardial infarction patients with IMH had residual myocardial iron 
at follow-up. This was associated with persistently elevated T2 values in the surrounding infarct tissue and adverse LV 
remodeling. IMH and residual myocardial iron may be potential therapeutic targets for preventing adverse LV remodeling 
in reperfused ST-segment–elevation myocardial infarction patients.  (Circ Cardiovasc Imaging. 2016;9:e004940. DOI: 
10.1161/CIRCIMAGING.116.004940.)
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2  Bulluck et al  Residual Iron in STEMI and Adverse LV Remodeling 
and ≈40% of STEMI patients develop intramyocardial hemor-
rhage (IMH)5 detected by cardiovascular magnetic resonance 
(CMR). Both MVO and IMH are associated with larger myo-
cardial infarct (MI) size, adverse left ventricular (LV) remod-
eling, and worse clinical outcomes.4,6–11
LV remodeling post MI refers to the intricate changes 
that occur in both the infarcted and remote myocardium on a 
molecular, structural, geometric, and functional level,12 and its 
occurrence predisposes to heart failure. The 3 partially overlap-
ping phases during post MI LV remodeling are the inflamma-
tory phase, the proliferative phase, and the maturation phase.13 
Numerous anti-inflammatory agents, such as glucocorticoids, 
monoclonal antibodies, C1 esterase inhibitors, metalloprotein-
ase inhibitors, phosphoinositide-3-kinase inhibitors, and immu-
noglobulin, have had promising results in the experimental 
setting, but have failed to translate into the clinical setting.14
Therefore, new therapeutic targets are required to prevent 
adverse LV remodeling and to improve clinical outcomes in 
reperfused STEMI patients. IMH and its iron degradation 
products have been shown to result in residual myocardial 
iron within the MI zone and have been proposed to have cyto-
toxic and proinflammatory effects on the myocardium.15,16 In 
some STEMI patients, areas of T2 abnormalities within the 
infarct zone have been shown to persist on CMR performed 
6 months post PPCI.17,18 The pathogenesis of the persistently 
elevated T2 signal and its relationship to adverse LV remodel-
ing remains to be determined.
Therefore, we hypothesized that patients with adverse LV 
remodeling were more likely to (1) have MVO/IMH on the 
acute scan; (2) have residual myocardial iron at follow-up; and 
(3) have persistently elevated T2 values in surrounding areas 
of residual myocardial iron that may be suggestive of persis-
tent myocardial inflammation.
Methods
Study Population
Fifty STEMI patients reperfused by PPCI were prospec-
tively recruited between August 2013 and July 2014. The 
main exclusion criteria were previous MI and standard 
recognized contraindications to CMR, such as estimated 
glomerular filtration rate <30 mL/min, ferromagnetic 
implants, and claustrophobia. The acute CMR scan was 
performed at 4±2 days post STEMI and a follow-up CMR 
scan at 5±2 months. The UK National Research Ethics Ser-
vice approved this study, and all patients provided written 
informed consent.
CMR Acquisition
CMR was performed on a 1.5 Tesla scanner (Magnetom 
Avanto; Siemens Medical Solutions) using a 32-channel 
phased-array cardiac coil. The imaging protocol included 
balanced steady-state free precession cines, native T1, T2, 
and T2* mapping (Work In Progress 448b; Siemens Health-
care), and late gadolinium enhancement (LGE) LV short-axis 
images. For the acute scan, whole LV short-axis coverage 
for T1 and T2 maps and 3 (basal, mid, and apical) LV short-
axis slices T2* maps were acquired. On the follow-up scan, 
only basal, mid, and apical short-axis slices were acquired for 
native T1, T2, and T2* maps.
Native T1 Mapping
Native T1 maps were acquired with a steady-state free pre-
cession–based Modified Look-Locker Inversion Recovery 
(MOLLI) sequence using a 5s(3s)3s modified sampling pro-
tocol.19 The acquisition parameters were flip angle =35°; pixel 
bandwidth =977 Hz/pixel; matrix =256×144; echo time =1.1 
ms; and slice thickness =6 mm. A pixel-wise colored T1 map 
was generated after performing motion correction and a non-
linear least-square curve fitting of the set of images acquired 
at different inversion times.
Figure 1. Basal left ventricular (LV) short axis of a patient with an acute inferior myocardial infarction (MI) depicting microvascular 
obstruction (MVO) on late gadolinium enhancement (LGE) scans with corresponding hypointense cores (red arrows) on the basal LV short 
axis T1, T2, and T2* maps and the follow-up scan with corresponding maps and areas of residual myocardial iron on the T2* map.
See Editorial by Dharmakumar 
See Clinical Perspective
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T2 Mapping
Colored T2 maps consisting of pixel-wise T2 values were gen-
erated inline after motion correction and fitting to estimate T2 
relaxation times20 after acquiring 3 single-shot images at dif-
ferent T2 preparation times (0, 24, and 55 ms, respectively). 
The acquisition parameters were flip angle =70°; pixel band-
width =930 Hz/pixel; matrix =116×192; echo time =1.1 ms; 
repetition time =3×R-R interval; and slice thickness =6 mm.
T2* Mapping
T2* maps were obtained using the following imaging param-
eters: bandwidth 814(×8) Hz/pixel; echo times×8: 2.7, 5, 7.3, 
9.6, 11.9, 14.2, 16.5, and 18.8 ms; flip angle =18°; acquisi-
tion matrix =256×115; and slice thickness =8 mm. A colored 
pixel-wise T2* map was generated by the scanner.
Late Gadolinium Enhancement
LGE images were acquired 10 to 15 minutes after the injec-
tion of 0.1 mmol/kg of gadoterate meglumine (Gd-DOTA 
marketed as Dotarem; Guerbet S.A., Paris, France), using 
either a standard segmented fast low-angle shot 2-dimen-
sional inversion-recovery gradient echo sequence (n=16) or 
a respiratory motion-corrected, free-breathing single-shot 
steady-state free precession averaged phase-sensitive inver-
sion recovery sequence21 (n=24).
Figure 1 shows an example of the basal short axis images 
acquired during the acute scan and at follow-up in a patient 
with an inferior STEMI.
CMR Analysis
Imaging analysis was performed using CVI42 software (Ver-
sion 5.1.2[303], Calgary, Canada).
Adverse LV remodeling was defined as a ≥20% increase 
in LV end-diastolic volume (EDV) between the acute and fol-
low-up scans.22
MI size was quantified in grams and as a percentage of 
the LV (%LV) using a signal-intensity threshold of 5 standard 
deviations (SD)23 above the mean remote myocardium. The 
area at risk (AAR) was assessed from the T2 maps using a 
signal intensity threshold of 2SD above the mean remote myo-
cardium and expressed as %LV. The presence of MVO (late 
MVO) was defined as areas of hypoenhancement on the LGE 
images and was quantified and expressed as %LV. Areas of 
MVO were included as part of the MI zone and AAR.
Figure 2. Method used to detect the area of high T2 (T2Infarct) around the area of residual myocardial iron (T2Core) and the remote 
myocardium (T2Remote) using a threshold of 2 standard deviation (SD) from the remote myocardium. LGE indicates late gadolinium 
enhancement.
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A hypointense core on the T2* maps with a T2* value 
of <20 ms was used to identify the presence of IMH on the 
acute scans and residual myocardial iron on the follow-up 
scans.24–28 The extent of IMH and residual iron was quanti-
fied using manual region of interest (ROI) delineation around 
the hypointense core on the basal, mid, and apical slices and 
expressed as %LV.
For the follow-up T1 and T2 maps, a ROI was manually 
drawn in hyperenhanced area using a signal intensity thresh-
old of 2SD from the remote myocardium (using the LGE 
images as reference) and was denoted as T1Infarct and T2Infarct, 
respectively.
A second ROI was copied from the hypointense core of 
the T2* map on to the T1 and T2 maps and denoted as T1Core 
and T2Core as illustrated in Figure 2.
In cases when there were no areas of hyperenhancement 
on the follow-up maps using a 2SD threshold, an ROI from 
the areas of LGE was copied on to the maps for representative 
values. An ROI was also drawn in the remote myocardium and 
expressed as T1Remote and T2Remote.
Statistical Analysis
Statistical analysis was performed using SPSS version 22 
(IBM Corporation, IL). Continuous data were expressed as 
mean±SD or median (interquartile range), and categorical 
data were reported as frequencies and percentages. Nor-
mality was assessed using Shapiro–Wilk test. Independent 
groups (those with and without IMH; with and without 
paired CMR scans; with and without residual iron at fol-
low-up; with and without adverse LV remodeling; without 
adverse LV remodeling but with and without residual iron) 
were compared with unpaired Student’s t test for normally 
distributed data and with Mann–Whitney U test for non-nor-
mally distributed data. Comparison between paired acute 
and follow-up scan was performed using paired Student’s t 
test for normally distributed data and Wilcoxon signed-rank 
test for non-normally distributed data. To compare T1 and 
T2 values in the remote, core, and infarct territories between 
patients and divided between those with and without resid-
ual iron, a linear mixed model was used, with the patients 
as a random factor and the territory within the patients 
(remote, core, and infarct) being a fixed factor. Compari-
son of 3 independent groups (no residual iron, residual iron 
only, and residual iron and adverse LV remodeling) was 
performed using Kruskal–Wallis Test and post hoc pairwise 
comparisons. Categorically variables such as incidence of 
MVO or IMH were compared using chi-squared test or 
Fisher exact test. Pearson rho correlation coefficient was 
assessed between MVO, acute MI size, IMH, and adverse 
LV remodeling as a continuous variable, respectively, and 
their correlations were compared. Receiver operating char-
acteristic curve was also used to compare the diagnostic 
performance of MVO, acute MI size, and IMH to predict 
adverse LV remodeling. All statistical tests were 2-tailed, 
and P<0.05 was considered statistically significant.
Results
Out of 50 STEMI patients recruited into the study, 48 
STEMI patients (mean age 59±13 years old, 88% male) 
completed the acute scan at 4±2 days post PPCI, and 40 
of these patients had a follow-up scan at 5±2 months. Two 
patients did not complete the scans because of unexpected 
claustrophobia. Characteristics of the 40 patients with a 
follow-up scan included in this study are listed in Table 
1. CMR details of these 40 patients are shown in Table 2. 
A CONSORT (Consolidated Standards of Reporting Tri-
als) flow diagram is provided in the Data Supplement. The 
median chest pain onset to PPCI time was 267 (122–330) 
minutes. No patients had heart failure at baseline. The MI 
size was 27.4±14.6 %LV, and T2-based AAR was 42.7±11.9 
%LV. MVO was present in 65% (26/40) of patients (mean 
MVO size of 13.6±7.2 %LV). In 24% of scans, the T2* 
maps (acute and follow-up) had to be excluded because they 
were not interpretable because of motion and off-resonance 
artifacts. After a mean follow-up of 5±2 months, 2 patients 
were rehospitalized for heart failure, and there were no 
deaths.
IMH and Edema-Based AAR
Patients with IMH had lower T2Core (50 [46–53] ms versus 
55 [52-59] ms; P=0.001) but similar T2Infarct (64 [62–64] ms 
versus 64 [62–69] ms; P=0.29) and T2 in the salvaged myo-
cardium (65 [61–68] ms versus 63 [62–67] ms; P=0.43). 
However, in patients with IMH, edema-based AAR was larger 
(46 [40–55] %LV versus 31 [24–43] %LV; P=0.009) and 
Table 1. Clinical Characteristics of STEMI Patients
Details Number
Number of patients 40
Male (%) 35 (88%)
Age (years) 59±13
Diabetes mellitus 8 (20%)
Hypertension 14 (35%)
Smoking 12 (30%)
Dyslipidemia 14 (35%)
Heart failure at baseline 0
Chest pain onset to PPCI time (minutes) 267 (122–330)
Infarct artery (%)
  LAD 24 (60%)
  RCA 14 (35%)
  Cx 2 (5%)
Treatment: on discharge
  Dual antiplatelet therapy 40 (100%)
  Beta blockers 40 (100%)
  ACEI/ARB 40 (100%)
  Statin 39 (98%)
  MRA 10 (25%)
ACEI/ARB indicates angiotensin-converting enzyme inhibitor/angiotensin 
receptor blocker; Cx, circumflex artery; LAD, left anterior descending artery; 
MRA, mineralocorticoid receptor antagonist; PPCI, primary percutaneous 
coronary intervention; RCA, right coronary artery; STEMI, ST-segment–elevation 
myocardial infarction; TIMI, Thrombolysis in Myocardial Infarction.
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myocardial salvage index was smaller (0.24 [0.16–0.43] ver-
sus 0.61 [0.36–0.88]; P=0.009), when compared with those 
without IMH.
Residual Myocardial Iron on the Follow-Up Scan in 
a Subset of Patients
A subset of 28 patients who completed the follow-up scans 
had matching and interpretable T2* maps. There was no dif-
ference in the CMR parameters between those with paired 
T2* maps (n=28) and those without (n=12; see Table in the 
Data Supplement). On the acute scan, 15/28 (54%) patients 
had IMH and 18/28 (64%) had MVO. Fifteen of 18 (83%) 
patients had MVO with IMH. On the follow-up scan, 13/15 
(87%) patients had evidence of residual myocardial iron.
T1 and T2 of the Core, Infarct Zone, and Remote 
Myocardium at Follow-Up
Using a linear mixed model to adjust for within-patient 
interaction, in patients without residual myocardial iron, 
there was no difference between T1Core and T1Infarct (1042 
[1015–1140] ms versus 1113 [1092–1140] ms; P=0.20), 
and T1Infarct was significantly higher than T1Remote (1113 
Table 2.  CMR Characteristics of STEMI Patients
 Acute Scan (n=40) Follow-Up Scan (n=40) P Value
EDV, mL 172±38 182±49 0.027
ESV, mL 90±30 88±38 0.60
EF, % 49±8 53±10 0.001
LV mass, g 112±35 104±26 0.051
Infarct size, % of LV 27.4±14.6 19.5±10.5 0.0001
Infarct size, g 20.2±13.6 14.4±9.4 0.0001
T2-based AAR, % of LV 42.0±12% … NA
MVO, n (%) 26 (65) … NA
MVO (n=26), %LV 5.1±3.5  NA
IMH (n=15), %LV 14.0 (6.0–21.2) … NA
Residual iron (n=13), %LV … 9.0 (4.0–10.3) NA
T2
Remote
, ms
  T2*<20 ms (n=15) 51 (48–53) 49 (46–51) 0.056
  T2*≥20 ms (n=13) 49 (48–51) 47 (45–48) 0.060
T2
Infarct
, ms
  T2*<20 ms (n=15) 64 (62–68) 60 (58–64) 0.017
  T2*≥20 ms (n=13) 64 (62–69) 53 (51–55) 0.001
T2
Core
, ms
  T2*<20 ms (n=15) 50 (46–53) 47 (45–50) 0.111
  T2*≥20 ms (n=13) 55 (52–59) 47 (45–49) 0.001
T1
Remote
, ms
  T2*<20 ms (n=15) 1051 (1023–1094) 1015 (989–1020) 0.002
  T2*≥20 ms (n=13) 990 (968–1018) 1007 (966–1039) 0.74
T1
Infarct
, ms
  T2*<20 ms (n=15) 1232 (1163–1338) 1162 (1132–1216) 0.014
  T2*≥20 ms (n=13) 1262 (1198–1286) 1113 (1092–1140) 0.001
T1
Core
, ms
  T2*<20 ms (n=15) 1016 (949–1061) 1004 (990–1028) 0.78
  T2*≥20 ms (n=13) 1140 (1086–1160) 1042 (1015–1140) 0.11
T2*
Remote
 (n=28) 32 (30–35) 34 (31–35) 0.52
T2*
Infarct
 (n=13) 29 (24–36) 33 (28–35) 0.80
T2*
Core
 (n=15) 10 (11–13) 15 (13–17) 0.013
AAR indicates area at risk; CMR, cardiovascular magnetic resonance; EDV, end-diastolic volume; EF, ejection fraction; ESV, 
end-systolic volume; IMH, intramyocardial hemorrhage; LV, left ventricle; MVO, microvascular obstruction; NA, not applicable; 
STEMI, ST-segment–elevation myocardial infarction.
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[1092–1140] ms versus 1007 [966–1039] ms; P<0.001). 
However, T2Core was lower than T2Infarct (47 [45–49] ms 
versus 53 [51–55] ms; P=0.001) and similar to T2Remote (47 
[45–49] ms versus 47 [45–48] ms; P=1.0), and T2Infarct was 
significantly higher than T2Remote (53 [51–55] ms versus 47 
[45–48] ms; P<0.001; Figure 3).
In patients with residual myocardial iron, both T1Core 
and T2Core were similar to T1Remote and T2Remote (T1: 1004 
[90–1028] ms versus 1015 [989–1020] ms; P=1.0; T2: 47 
[45–50] ms versus 49 [46–51] ms; P=1.0) but significantly 
lower than T1Infarct and T2Infarct (T1: 1004 [90–1028] ms versus 
1162 [1132–1216] ms; P<0.001; T2: 47 [45–50] ms versus 60 
[58–64] ms; P<0.001) respectively (Figure 3).
Patients with residual myocardial iron had lower T1Core, 
similar T2Core, and higher T1Infarct and T2Infarct when com-
pared with patients without. There was no difference in the 
T1Remote and T2Remote between these 2 groups as illustrated in 
Figure 3.
Figure 4 shows an example of 3 patients with acute and 
follow-up CMR images showing MVO, IMH, residual myo-
cardial iron, and persistently elevated T2 in the surrounding 
myocardium within the infarct zone at follow-up.
IMH and Adverse LV Remodeling
Eight out of 40 (20%) patients developed adverse LV remod-
eling. Patients with adverse LV remodeling had larger MI 
size (30.1±7.3 %LV versus 16.9±9.8 %LV; P=0.01), had an 
increased incidence (100% versus 50%; P=0.10) and extent 
of MVO (8.0±3.2 %LV versus 3.6±2.6 %LV; P=0.001), and 
were more likely to have IMH (100% versus 60%; P=0.04) 
on the acute scans when compared with those without adverse 
LV remodeling.
Residual Myocardial Iron and Adverse LV 
Remodeling
In patients with adverse LV remodeling, T2Infarct was signifi-
cantly higher than in those without adverse LV remodeling 
and without residual myocardial iron (60 [54–64] ms versus 
53 [51–56] ms; P=0.025), but similar to those with residual 
myocardial iron but no adverse LV remodeling (60 [54–64] 
ms versus 60 [58–63] ms; P=1.0) as shown in Figure 5A.
However, when looking at those patients who did not 
develop adverse LV remodeling, those with residual iron had 
a significantly higher change in EDV (8% [−2% to 14%] ver-
sus −4% [−7% to 5%]; P=0.043) when compared with those 
patients without residual myocardial iron (Figure 5B).
Relationship Between Acute MI Size, MVO, and 
IMH and Adverse LV Remodeling
Acute MI size, extent of MVO, and IMH correlated with the 
change in LV EDV (Pearson’s rho of 0.64, 0.59, and 0.66, 
respectively; P values of 0.18 and 0.62, respectively, for corre-
lation coefficient comparison) and performed equally well on 
receiver operating characteristic curve for predicting adverse 
LV remodeling (area under the curve: 0.99, 0.94, and 0.95, 
respectively, P=0.19 for receiver operating characteristic 
curve comparison).
Discussion
The major findings of our study are as follows: (1) the 
majority of STEMI patients treated by PPCI with MVO 
also had IMH (83%); (2) many of these patients with IMH 
had residual myocardial iron at follow-up (87%), and these 
patients had elevated T2 values on CMR in the surround-
ing myocardium in the MI zone, suggestive of delayed 
Figure 3. Box plots of T1 (A) and T2 (B) values of the core, infarct, and remote myocardium in patients with and without residual 
myocardial iron.
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resolution of edema or inflammation; (3) all patients with 
adverse LV remodeling had residual myocardial iron and 
elevated T2 in the surrounding myocardium in the MI zone; 
and (4) acute MI size, the extent of MVO, and IMH cor-
related equally well with the change in LV EDV and per-
formed with high diagnostic accuracy to predict adverse 
LV remodeling.
Furthermore, in patients not meeting the definition for 
adverse LV remodeling, those with residual myocardial iron 
had a larger percentage increase in EDV than those without 
residual myocardial iron, confirming an overlap between 
the inflammatory phase and proliferation phase previously 
described.13 Although T1 values were also higher in the MI 
zone surrounding areas of residual myocardial iron com-
pared with those without, this difference in T1 may have been 
because of the complex interplay between fibrosis, edema, 
and the development of early fatty metaplasia29 in the chronic 
phase of a STEMI.
It is well recognized that IMH is associated with larger MI 
size, adverse LV remodeling, and poor clinical outcomes6,9,30,31 
and may be proarrhythmic.32,33 Although our study was purely 
based on tissue characterization, these findings support the 
current literature that residual myocardial iron may play a role 
in the inflammatory phase of adverse LV remodeling. Using 
T2* imaging, Kali et al15 have recently shown in a small cohort 
of 15 STEMI patients that the presence of IMH on the acute 
CMR scans was associated with residual myocardial iron at 
6 months. They also used immunohistochemical analysis of 
canine hearts subjected to acute MI to show evidence of local-
ized accumulation of macrophages at the sites of chronic iron 
deposition at follow-up, suggesting a prolonged inflammatory 
response at the sites of residual myocardial iron.15 Roghi et 
al16 also showed in a small cohort of 15 STEMI patients that 
those with MVO and IMH had higher levels of nontransferrin-
bound iron—these have previously been linked to cardiotox-
icity in thalassemia major. Our study is the first study to use 
T2 mapping for the detection of delayed resolution of edema 
associated with residual myocardial iron in patients with IMH.
Recently, Carrick et al34 performed serial scanning in 30 
patients and elegantly described the time course of MVO and 
IMH. MVO was already present at 4 to 12 hours and remained 
stable up to a mean of 2.9 days and then reduced by day 
10. IMH, on the contrary, peaked at a mean of 2.9 days and 
decreased by day 10. Of note, 13 patients had IMH on day 2.9, 
and only 4 patients displayed residual myocardial iron by 6 
months. Based on brain imaging data,35 degradation of hemo-
globin eventually leads to ferritin and hemosiderin deposits, 
and the fact that the majority of their patients had no residual 
Figure 4. Examples of 3 patients (A, B, and C) with acute and follow-up scans and the red arrows showing areas of microvascular 
obstruction (MVO), intramyocardial hemorrhage (IMH), and residual myocardial iron and the black arrows showing areas of hyperenhance-
ment on the T2 maps. LGE indicates late gadolinium enhancement.
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myocardial iron in their study may suggest that those patients 
had small areas of IMH that were rapidly cleared by the mac-
rophages. They reported the presence of IMH in 41% of their 
total cohort of 245 patients with analyzable T2* data, and it is 
likely that they may have underestimated the true prevalence 
of IMH because the CMR was performed at a mean of 2.1 
days and some patients who would have subsequently devel-
oped IMH up to 3 days post reperfusion may not have been 
detected.
Pooling the results of these 3 studies demonstrating resid-
ual myocardial iron after STEMI, Kali et al15 (acute scan: 11 
out of 15 patients with IMH; follow-up scan: 11 with residual 
myocardial iron), Carrick et al34 (acute scan: 13 out of 30 
patients with IMH; follow-up scan: 4 with residual myocar-
dial iron), and our study (acute scan: 15 out of 28 patients with 
IMH; follow-up scan: 13 with residual myocardial iron), the 
prevalence of IMH by T2* mapping was 53% (39/73), and 72% 
(28/39) had residual myocardial iron at follow-up. Although 
IMH is likely to be confounded by larger infarct size, whether 
specifically targeting these patients with anti-inflammatory 
agents or chelation therapy needs to be investigated in further 
studies aiming to prevent adverse LV remodeling.
Limitations
A significant proportion of the T2* maps were not interpre-
table in our study, and this partly highlights the challenge 
of performing a comprehensive CMR scan with multipara-
metric mapping in patients with an acute STEMI and may 
be partly because of the suboptimal per-slice rather than 
whole-heart shimming protocol we used. Of note, 18% of 
T2* data were not available in the large study by Carrick et 
al34 either because of patients' intolerance of the scan or non-
interpretable T2* maps. Although we quantified the extent 
of IMH in our study, we only used basal, mid, and apical 
short-axis T2* maps, and the quantification may have been 
more accurate if whole LV coverage T2* maps had been 
performed. Furthermore, only basal, mid, and apical short-
axis T1 and T2 maps were acquired at follow-up. We used 
2 different LGE sequences, and the difference in signal-to-
noise ratio between the 2 may have affected the MVO size 
quantification. LGE images were acquired between 10 and 
15 minutes, and this may have overestimated the MI and 
MVO size, and whether acquiring LGE images at 25 min-
utes36 would have yielded different diagnostic performances 
for LGE, MVO, and IMH to predict adverse LV remodeling 
warrants further investigation. Receiver operating character-
istic curve analysis was performed in 28 patients only, and 
therefore, we did not provide data on sensitivity/specificity 
and cutoff values because of small sample size. We did not 
measure blood inflammation markers to support the proposal 
of persistent inflammation because of residual myocardial 
iron in these patients. Histological validation is required to 
determine whether the elevated T2 values in the myocardium 
surrounding residual iron in the infarct zone was because of 
persistent inflammation. Our study was small, and we could 
not establish a causal relationship between IMH and adverse 
LV remodeling.
Conclusion
The majority of reperfused STEMI patients with IMH had 
residual myocardial iron at follow-up. This was associated 
with adverse LV remodeling and persistently elevated T2 val-
ues in the surrounding infarct tissue and may be suggestive 
of ongoing inflammation. Furthermore, IMH was as strongly 
associated with adverse LV remodeling as acute MI size and 
MVO. Therefore, patients with IMH or residual myocardial 
iron could be future potential targets for therapeutic interven-
tions with anti-inflammatory agents or chelation therapy aim-
ing to prevent adverse LV remodeling and improve clinical 
outcomes in these patients.
Figure 5. A, T2 values in the infarct zone in patients with and without residual myocardial iron. B, Change in end-diastolic volume (EDV) 
in patients without adverse left ventricular (LV) remodeling and with or without residual myocardial iron.
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CLINICAL PERSPECTIVE
It is already known that ≈50% of ST-segment–elevation myocardial infarction patients develop microvascular obstruction, 
despite prompt reperfusion of the epicardial vessel by primary percutaneous coronary intervention, and this is associated 
with adverse left ventricular remodeling and worse clinical outcomes. However, the impact of intramyocardial hemorrhage 
on the same end points has not been clearly established. Our study analyzed paired cardiovascular magnetic resonance 
scans in 40 ST-segment–elevation myocardial infarction patients within 1 week and at 5 months after primary percutaneous 
coronary intervention. Twenty-eight patients also had paired T2* mapping data available. We found that the large majority 
(83%) of the patients with microvascular obstruction also had intramyocardial hemorrhage. Many of these patients went on 
to have residual myocardial iron at follow-up (87%) as identified by T2* mapping, and this was associated with persistently 
elevated T2 values in the surrounding infarct tissue. Furthermore, intramyocardial hemorrhage was as strongly associated 
with adverse left ventricular remodeling as acute myocardial infarction size and microvascular obstruction. These findings 
suggest that intramyocardial hemorrhage and residual iron within the infarct zone may be associated with delayed resolu-
tion of edema or inflammation and adverse left ventricular remodeling. Therefore, whether anti-inflammatory agents or iron 
chelation therapy may prevent adverse left ventricular remodeling and improve clinical outcomes in ST-segment–elevation 
myocardial infarction patients treated by primary percutaneous coronary intervention warrants further investigation.
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 Patients with 
paired T2* 
maps  
(n=28) 
Patients 
without paired 
T2* maps 
(n=12) 
P value 
EDV/ml 
 
173±40 170±31 0.79 
ESV/ml 
 
91±32 87±24 0.71 
EF/% 
 
48±9 50±7 0.58 
Mass/ g 
 
119±33 104±24 0.15 
Change in EDV/ ml 
 
7±16 3±13 0.44 
Acute infarct size/ %LV 
 
26.7±15.2 28.8±13.6 0.69 
Follow-up Infarct size/ 
%LV 
 
18.5±11.1 22.0±9.8 0.36 
T2-based AAR/ % of LV 
 
42.7±12.3 40.3±11.8 0.56 
MVO/ n (%) 
 
18 (64) 8 (67%) 0.59 
Adverse LV remodeling/ n 
(%) 
 
6 (21%) 2 (17%) 0.55 
Acute scan 
T2Remote  
T2Core 
T2Infarct 
 
50 (48-52) 
52 (48-55) 
64 (62-68) 
 
 
50 (48-52) 
51 (48-54) 
65 (64-66) 
 
0.85 
0.96 
0.80 
 
Follow-up scan 
T2Remote  
T2Core 
T2Infarct 
 
48 (46-50) 
47 (45-49) 
57 (53-61) 
 
47 (45-49) 
47 (46-48) 
54 (52-57) 
 
0.63 
0.90 
0.25 
 
